Morgan Stanley Fortress Biotech, Inc. Transaction History

Morgan Stanley

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$0.28 - $0.65 $29,320 - $68,064	-104,715 Reduced 60.19%	69,266 $20,000
Q2 2023 Aug 14, 2023	SELL	$0.49 - $0.82 $1,339 - $2,241	-2,734 Reduced 1.55%	173,981 $95,000
Q1 2023 May 15, 2023	BUY	$0.65 - $1.1 $44,938 - $76,049	69,136 Added 64.27%	176,715 $144,000
Q4 2022 Feb 14, 2023	BUY	$0.48 - $13.5 $7,388 - $207,792	15,392 Added 16.7%	107,579 $71,000
Q3 2022 Nov 14, 2022	SELL	$0.79 - $22.0 $58,200 - $1.62 Million	-73,672 Reduced 44.42%	92,187 $79,000
Q2 2022 Oct 27, 2022	BUY	$0.8 - $1.5 $8,356 - $15,669	10,446 Added 6.72%	165,859 $139,000
Q2 2022 Aug 15, 2022	BUY	$0.8 - $1.5 $8,356 - $15,669	10,446 Added 6.72%	165,859 $139,000
Q1 2022 Oct 27, 2022	SELL	$1.24 - $2.75 $12,953 - $28,726	-10,446 Reduced 6.3%	155,413 $211,000
Q1 2022 May 13, 2022	SELL	$1.24 - $2.75 $72,935 - $161,752	-58,819 Reduced 27.46%	155,413 $211,000
Q4 2021 Feb 14, 2022	SELL	$2.42 - $3.65 $168,732 - $254,492	-69,724 Reduced 24.55%	214,232 $536,000
Q3 2021 Nov 15, 2021	BUY	$2.82 - $3.7 $800,755 - $1.05 Million	283,956 New	283,956 $914,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $185M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.